Characterizing Treatment Non-responders vs. Responders in Completed Alzheimer’s Disease Clinical Trials

Alzheimer’s disease (AD) patients have varying responses to AD drugs and there may be no single treatment for all AD patients. Trial after trial shows that identifying non-responsive and responsive subgroups and their corresponding moderators will provide better insights into subject selection and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dulin, Ling, Yaobin, Harris, Kristofer, Schulz, Paul E., Jiang, Xiaoqian, Kim, Yejin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635230/
https://www.ncbi.nlm.nih.gov/pubmed/37961216
http://dx.doi.org/10.1101/2023.10.27.23297685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635230/
https://www.ncbi.nlm.nih.gov/pubmed/37961216
http://dx.doi.org/10.1101/2023.10.27.23297685

Ejemplares similares